Logo (Nivestym 01)
Nivestym Injection, Solution
Product Images NDC 0069-0293
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 44 technical images submitted to the FDA as part of the official labeling for Nivestym (NDC 0069-0293). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Nivestym 02)
Figure A (Nivestym 03)
An instructional diagram of a syringe for Nivestym (filgrastim-aafi) injection. The illustration labels syringe components including needle cover, dose markings, syringe barrel with viewing window and label area for expiration date, needle guard with conical base, plunger stopper, finger grips, and plunger rod.*
Figure B (Nivestym 04)
An instructional illustration showing items related to injectable medication disposal and care, including a sharps disposal container, an alcohol wipe packet, a cotton ball, and an adhesive bandage. Each item is labeled for identification, indicating safe post-injection handling and disposal practices.*
Figure C (Nivestym 05)
An illustration showing the internal components of a prefilled syringe for subcutaneous injection. The diagram details the syringe barrel, plunger, needle hub, and needle cover, demonstrating the syringe's mechanism and parts for delivering an injection.*
Figure D (Nivestym 06)
A black and white line drawing illustration of a prefilled syringe designed for subcutaneous injection. The syringe includes a plunger, barrel, and needle cap. The image shows an internal view highlighting the syringe's components and construction.*
Figure E (Nivestym 07)
An instructional diagram showing recommended subcutaneous injection sites on a human body. The front view highlights the upper arm, stomach area (abdomen), and thigh, while the back view indicates the upper arm and buttocks as injection sites.*
Figure F (Nivestym 08)
An instructional diagram showing a hand pressing a cotton ball or gauze pad against the upper thigh, likely illustrating a step in a subcutaneous injection procedure.*
Figure G (Nivestym 09)
Instructional illustration showing two steps for disposing of a used injection needle and syringe. The first step depicts hands pulling the needle cap straight off the syringe. The second step shows a hand placing the capped needle into a sharps disposal container.*
Figure H (Nivestym 10)
An instructional illustration showing two hands preparing a syringe injection. One hand holds the syringe vertically, while the other hand is pulling back the needle cap in the direction indicated by an arrow to remove it.*
Figure I (Nivestym 11)
An instructional illustration showing hands holding a prefilled syringe with a dosing plunger. Two labeled steps demonstrate how to adjust the partial dose by aligning the plunger stopper to the black dose line. Step 1 shows the initial position with dose markings from 0.2 to 0.5 mL, and Step 2 shows dose setting with the conical base of the plunger stopper behind the dose line.*
Figure J (Nivestym 12)
An instructional illustration showing a hand pressing on the skin of a person's upper arm. The image depicts a step in the process of administering a subcutaneous injection, likely related to the use of Nivestym (filgrastim-aafi) injection solution.*
Figure K (Nivestym 13)
An instructional diagram showing the proper subcutaneous injection technique for Nivestym (filgrastim-aafi) injection, solution. It depicts a hand holding the injection device at a 90-degree angle to the skin and an inset showing an alternative 45-degree angle, illustrating how to insert the needle into the skin on the thigh area.*
Figure L (Nivestym 14)
An instructional diagram showing a hand administering a subcutaneous injection with a syringe into the thigh. The illustration depicts correct hand positioning and the angle of needle insertion for injection.*
Figure M (Nivestym 15)
An instructional illustration demonstrating the subcutaneous injection technique using a syringe, showing a hand holding the syringe with the needle inserted into the skin above the knee on a bent leg.*
Figure N (Nivestym 16)
An instructional diagram showing the proper use of the Nivestym (filgrastim-aafi) injection syringe. It depicts a hand holding the syringe with an arrow indicating the direction to pull the plunger. A zoomed-in inset illustrates the needle in the retracted position within the syringe barrel.*
Figure O (Nivestym 17)
An instructional line drawing showing a hand placing a small medical device or injection applicator on the bent knee of a person, suggesting a site for subcutaneous administration.*
Figure P (Nivestym 18)
An instructional line drawing showing a hand holding a syringe with needle downward, positioned above a sharps disposal container. The image illustrates the safe disposal of the syringe by pointing it into the container before release.*
Logo (Nivestym 19)
Figure (Nivestym 20)
An instructional illustration showing components for injection preparation and administration. It includes a vial, a disposable syringe with plunger and needle cap, two alcohol wipes, a small blue tablet or pellet, an oblong tablet or pill, and a red sharps disposal container.*
Figure (Nivestym 21)
Illustration showing hands preparing a medication vial: one hand holds a vial while the other hand peels off a protective cap from the vial's top, depicting initial steps in medication preparation, relevant to injectable drugs like Nivestym (filgrastim-aafi).*
Figure (Nivestym 22)
Illustration showing the proper disposal of a syringe after use. One hand holds a syringe and withdraws the needle cap upwards, while another hand drops the capped syringe into a red sharps disposal container with an open lid, demonstrating safe injection waste handling.*
Figure (Nivestym 23)
An instructional illustration showing a pair of hands preparing an injection. One hand holds a vial steady on a surface while the other hand inserts a syringe needle into the vial, with a downward arrow indicating the direction of needle insertion.*
Figure (Nivestym 24)
An instructional illustration showing hands drawing liquid from a vial into a syringe, commonly used for preparing a subcutaneous injection.*
Figure (Nivestym 25)
An illustration showing two hands preparing a syringe by drawing a solution from a vial, demonstrating proper aseptic technique for medication injection preparation.*
Figure (Nivestym 26)
An instructional diagram showing recommended injection sites for Nivestym (filgrastim-aafi) subcutaneous injection. The front view highlights the upper arm, stomach area (abdomen), and thigh as injection sites. The back view shows the upper arm and buttocks areas as suitable locations for injection.*
Figure (Nivestym 27)
Illustration showing a person pinching the skin on their lower abdomen with one hand, indicating an injection site for subcutaneous administration. Arrows point to the pinched skin area, suggesting proper technique for an injection in the abdominal region.*
Figure (Nivestym 28)
An instructional illustration showing the proper method for subcutaneous injection using a syringe. One hand holds the syringe vertically at a 90-degree angle or, alternatively, a 45-degree angle, while the other hand pinches the skin. The syringe is then inserted into the skin with a downward motion.*
Figure (Nivestym 29)
An instructional illustration showing a hand holding a syringe injecting a subcutaneous injection into the skin of another person's arm. An arrow indicates the downward direction for injection.*
Figure (Nivestym 30)
Instructional illustration showing a hand holding a syringe for subcutaneous injection, with an arrow indicating upward movement, and a lower image depicting the injection site on skin prepared for administration.*
Figure (Nivestym 31)
An instructional illustration showing a hand holding a syringe with a needle cap being removed and inserted downward into an upright vial in a red container, demonstrating how to prepare an injection using the vial.*
Logo (Nivestym 32)
Principal Display Panel (1 mL Vial Label)
Nivestym (filgrastim-aafi) Injection 300 mcg/mL single-dose vial label. The label identifies the drug as a subcutaneous injection biosimilar, distributed by Pfizer Labs, division of Pfizer Inc. It provides storage instructions (2° to 8°C) and notes it is Rx only with dosage directions in the package insert.*
Principal Display Panel (1 mL Vial Carton)
Packaging label for Nivestym (filgrastim-aafi) Injection, 300 mcg/mL, a sterile solution for intravenous or subcutaneous use. The label indicates this is a human prescription drug available in single-dose 1 mL vials. It is marketed by Pfizer Laboratories, a division of Pfizer Inc, and is identified as a biosimilar product. The label includes usage instructions and storage information.*
Principal Display Panel (1.6 mL Vial Label)
Label for Nivestym (filgrastim-aafi) Injection, 480 mcg/1.6 mL, a human prescription drug in single-dose vial form. The label notes storage instructions at 2° to 8°C, manufacturer Hospira, Inc., a Pfizer company, and distribution by Pfizer Labs division of Pfizer Inc.*
Principal Display Panel (1.6 mL Vial Carton)
Nivestym 480 mcg/1.6 mL injection label for filgrastim-aafi by Pfizer Laboratories. The label indicates a single-dose vial containing 1.6 mL solution for subcutaneous or intravenous use. It highlights the strength (480 mcg/1.6 mL), product name, generic name, and specifies no preservative in the sterile solution. The label includes the Pfizer Biosimilars logo and usage instructions emphasizing single-dose and refrigerated storage.*
Principal Display Panel (0.5 mL Syringe Label)
Label for Nivestym (filgrastim-aafi) Injection, 300 mcg/0.5 mL, a human prescription drug for subcutaneous use. The label indicates a single-dose prefilled syringe with needle guard. It includes dosage volume markings from 0.1 to 0.5 mL, barcode, lot and expiration date fields, and states it is manufactured by Hospira Inc, a Pfizer company.*
Principal Display Panel (0.5 mL Syringe Carton)
Nivestym 300 mcg/0.5 mL injection packaging label for subcutaneous solution by Pfizer Biosimilars. The label states filgrastim-aafi as the active ingredient and notes it is a single-dose prefilled syringe with needle guard. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F) and protection from light. The label includes Pfizer branding and biosimilars designation.*
Principal Display Panel (0.5 mL Syringe Carton)
Packaging label for Nivestym (filgrastim-aafi) Injection, 300 mcg/0.5 mL subcutaneous injection. The label indicates a sterile solution with no preservative, supplied as a single-dose prefilled syringe with needle guard. The packaging design includes Pfizer Biosimilars branding and states the product is for subcutaneous use only.*
Principal Display Panel (0.5 mL Syringe Carton)
Packaging label for Nivestym 300 mcg/0.5 mL injection, a subcutaneous injectable solution of filgrastim-aafi. The label shows a single-dose prefilled syringe with needle guard, sterile solution with no preservative. It includes Pfizer Biosimilars branding and indicates it is for subcutaneous use only.*
Principal Display Panel (0.8 mL Syringe Label)
Label for Nivestym (filgrastim-aafi) injection, 480 mcg/0.8 mL, a subcutaneous injection solution in a single-dose prefilled syringe with needle guard. Manufactured by Hospira Inc, a Pfizer Company, Lake Forest, IL. Includes NDC 0069-0292-01 and dosage markings from 0.2 to 0.8 mL.*
Principal Display Panel (0.8 mL Syringe Carton)
Packaging label for Nivestym (filgrastim-aafi) injection, 480 mcg/0.8 mL, a subcutaneous single-dose prefilled syringe with needle guard. The label includes storage instructions (refrigerate at 2° to 8°C, do not freeze or shake) and states the product is a sterile solution with no preservative. Labeler is Pfizer Biosimilars.*
Principal Display Panel (0.8 mL Syringe Carton)
Nivestym 480 mcg/0.8 mL filgrastim-aafi injection carton label for subcutaneous use. The packaging indicates single-dose prefilled syringes with needle guards, sterile solution with no preservative, distributed by Pfizer Biosimilars. The label highlights the recombinant Granulocyte Colony Stimulating Factor derived from E. coli, and includes NDC 0069-0292-10.*
Principal Display Panel (0.8 mL Sryinge Carton)
Nivestym 480 mcg/0.8 mL injection solution label for a single-dose prefilled syringe with needle guard by Pfizer Biosimilars. The label states subcutaneous use only, sterile solution with no preservative, and identifies the active ingredient as filgrastim-aafi, a recombinant Granulocyte Colony Stimulating Factor derived from E. coli.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
